FormWeb • ado-trastuzumab emtansine

UNC Health

UNC Health Medication Formulary

Change Request Form Chemical/SDS Search UNC Health.org

QR Code

Add Formweb to your mobile device

Android iOS

Click here to submit safety event reports via SAFE

UNC Health

UNC Health Medication Formulary

Change Request Form Chemical/SDS Search UNC Health.org

Search results for:

ado-trastuzumab emtansine

ado-trastuzumab emtansine

Hazardous Drugs System Hazardous Drugs List Link

Drug Name	Form	Strength	ARHS	Blue Ridge	Caldwell	Chatham	Johnston	Lenoir	Medical Center	Nash	Pardee	Rex	Rockingham	Southeastern	Wayne	Youth Behavioral Health
Ado-Trastuzumab Emtansine	POWDER FOR INJECTION, INTRAVENOUS	100 mg
Ado-Trastuzumab Emtansine	POWDER FOR INJECTION, INTRAVENOUS	160 mg

UNC Health

Hazardous Medication

Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Outside of the Pharmacy
Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Inside of the Pharmacy

System Formulary Restriction:

Use of ado-trastuzumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)

Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet

Med Center
UNC Medical Center Formulary Restrictions

Last updated: Mar. 13, 2026

Black Box Warning: Hepatotoxicity, Cardiac Toxicity, Embryo-Fetal Toxicity

This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.

Copyright © 2026 Rpharmy, LLC All Rights Reserved